Sarne et al. created pyrosequencing assays for CDH1, CDKN2A, RASSF1A, TERT, and WT1; in 144 FFPE NSCLC samples, significant hypermethylation was observed for TERT and WT1 (not consistently for CDH1), with supportive cell-line studies. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.